The Antidiabetic Agent Glibenclamide Protects Airway Hyperresponsiveness and Inflammation in Mice

详细信息    查看全文

• 作者：Wei Cui (1)
  Shufang Zhang (2)
  Zhijian Cai (3)
  Xinlei Hu (2)
  Ruifeng Zhang (4)
  Yong Wang (5)
  Na Li (1)
  Zhihua Chen (6)
  Gensheng Zhang (1)
  
  1. Department of Critical Care Medicine ; Second Affiliated Hospital ; Zhejiang University School of Medicine ; Hangzhou ; 310009 ; China
  2. Binjiang Branch ; Second Affiliated Hospital ; Zhejiang University School of Medicine ; Hangzhou ; 310009 ; China
  3. Department of Immunology ; Zhejiang University ; Hangzhou ; Zhejiang ; 310009 ; China
  4. Department of Respiratory Medicine of Sir Run Run Shaw Hospital ; Zhejiang University School of Medicine ; Hangzhou ; Zhejiang ; 310009 ; China
  5. Department of General Surgery ; Ningbo First Hospital ; Ningbo ; Zhejiang ; 315010 ; China
  6. Department of Respiratory and Critical Care Medicine ; Second Affiliated Hospital ; Zhejiang University School of Medicine ; Hangzhou ; Zhejiang ; 310009 ; China
  
• 关键词：airway hyperresponsiveness ; airway inflammation ; asthma ; glibenclamide ; sulfonylurea receptor 1
• 刊名：Inflammation
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：38
• 期：2
• 页码：835-845
• 全文大小：3,142 KB
• 参考文献：1. Riddle, MC (2003) Editorial: sulfonylureas differ in effects on ischemic preconditioning鈥攊s it time to retire glyburide?. Journal of Clinical Endocrinology and Metabolism 88: pp. 528-530 CrossRef
  2. Simard, JM, Geng, Z, Woo, SK (2009) Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 29: pp. 317-330 CrossRef
  3. Figura, M, Chilton, L, Liacini, A (2009) Blockade of K(ATP) channels reduces endothelial hyperpolarization and leukocyte recruitment upon reperfusion after hypoxia. American Journal of Transplantation 9: pp. 687-696 CrossRef
  4. Pompermayer, K, Amaral, FA, Fagundes, CT (2007) Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. European Journal of Pharmacology 556: pp. 215-222 CrossRef
  5. Abdallah, DM, Nassar, NN, Abd-El-Salam, RM (2011) Glibenclamide ameliorates ischemia-reperfusion injury via modulating oxidative stress and inflammatory mediators in the rat hippocampus. Brain Research 1385: pp. 257-262 CrossRef
  6. Schmid, D, Svoboda, M, Sorgner, A (2011) Glibenclamide reduces proinflammatory cytokines in an ex vivo model of human endotoxinaemia under hypoxaemic conditions. Life Sciences 89: pp. 725-734 CrossRef
  7. Koh, GC, Maude, RR, Schreiber, MF (2011) Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clinical Infectious Diseases 52: pp. 717-725 CrossRef
  8. Lamkanfi, M, Mueller, JL, Vitari, AC (2009) Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. Journal of Cell Biology 187: pp. 61-70 CrossRef
  9. Silva-Santos, JE, Santos-Silva, MC, Cunha Fde, Q, Assreuy, J (2002) The role of ATP-sensitive potassium channels in neutrophil migration and plasma exudation. Journal of Pharmacology and Experimental Therapeutics 300: pp. 946-951 CrossRef
  10. Umetsu, DT, McIntire, JJ, Akbari, O, Macaubas, C, DeKruyff, RH (2002) Asthma: an epidemic of dysregulated immunity. Nature Immunology 3: pp. 715-720 CrossRef
  11. Bankers-Fulbright, JL, Kephart, GM, Loegering, DA (1998) Sulfonylureas inhibit cytokine-induced eosinophil survival and activation. Journal of Immunology 160: pp. 5546-5553
  12. Song, P, Rocchi, D, Lazzarotti, M, Crimi, E, Rehder, K, Brusasco, V (1996) Postjunctional effect of pinacidil on the contractility of isolated bovine trachealis. European Respiratory Journal 9: pp. 2057-2063 CrossRef
  13. Buchheit, KH, Manley, PW, Quast, U, Russ, U, Mazzoni, L, Fozard, JR (2002) KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects. Naunyn-Schmiedeberg鈥檚 Archives of Pharmacology 365: pp. 220-230 CrossRef
  14. Yang, G, Tang, G, Zhang, L, Wu, L, Wang, R (2011) The pathogenic role of cystathionine 纬-lyase/hydrogen sulfide in streptozotocin-induced diabetes in mice. American Journal of Pathology 179: pp. 869-879 CrossRef
  15. Zhang, G, Wang, P, Yang, G, Cao, Q, Wang, R (2013) The inhibitory role of hydrogen sulfide in airway hyperresponsiveness and inflammation in a mouse model of asthma. American Journal of Pathology 182: pp. 1188-1195 CrossRef
  16. Qin, XJ, Zhang, GS, Zhang, X (2012) Protein tyrosine phosphatase SHP2 regulates TGF-beta1 production in airway epithelia and asthmatic airway remodeling in mice. Allergy 67: pp. 1547-1556
  17. Zhang, G, Wang, P, Qiu, Z (2013) Distant lymph nodes serve as pools of Th1 cells induced by neonatal BCG vaccination for the prevention of asthma in mice. Allergy 68: pp. 330-338 CrossRef
  18. Crocker, IC, Church, MK, Newton, S, Townley, RG (1998) Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines. Annals of Allergy, Asthma, and Immunology 80: pp. 509-516 CrossRef
  19. Tattersfield, AE (2006) Current issues with beta2-adrenoceptor agonists: historical background. Clinical Reviews in Allergy and Immunology 31: pp. 107-118 CrossRef
  20. Cockcroft, DW, Davis, BE (2006) Mechanisms of airway hyperresponsiveness. Journal of Allergy and Clinical Immunology 118: pp. 551-559 CrossRef
  21. Kuperman, DA, Huang, X, Koth, LL (2002) Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nature Medicine 8: pp. 885-889
  22. Rosenberg, HF, Phipps, S, Foster, PS (2007) Eosinophil trafficking in allergy and asthma. Journal of Allergy and Clinical Immunology 119: pp. 1303-1310 CrossRef
  23. Voehringer, D, Shinkai, K, Locksley, RM (2004) Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 20: pp. 267-277 CrossRef
  24. Ponte-Sucre, A, Figarella, K, Moll, H (2001) Experimental leishmaniasis: the glibenclamide-triggered decrease in parasite growth correlates with changes in macrophage features. Immunopharmacology and Immunotoxicology 23: pp. 477-486 CrossRef
  25. Nakajima, H, Sano, H, Nishimura, T, Yoshida, S, Iwamoto, I (1994) Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. Journal of Experimental Medicine 179: pp. 1145-1154 CrossRef
  26. Khew-Goodall, Y., C. Wadham, B. N. Stein, J.R. Gamble, M.A. Vadas. Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 19(6): 1421鈥?429.
  27. Fukushi, J, Ono, M, Morikawa, W, Iwamoto, Y, Kuwano, M (2000) The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13. Journal of Immunology 165: pp. 2818-2823 CrossRef
  28. Desmet, C, Gosset, P, Pajak, B (2004) Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. Journal of Immunology 173: pp. 5766-5775 CrossRef
  29. Santos, G, Kutuzov, MA, Ridge, KM (2012) The inflammasome in lung diseases. American Journal of Physiology - Lung Cellular and Molecular Physiology 303: pp. L627-L633 CrossRef
  30. Seino, S (1999) ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annual Review of Physiology 61: pp. 337-362 CrossRef
  31. Simard, JM, Chen, M, Tarasov, KV (2006) Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nature Medicine 12: pp. 433-440 CrossRef
  32. Chen, M, Dong, Y, Simard, JM (2003) Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. Journal of Neuroscience 23: pp. 8568-8577
  33. Simard, JM, Tsymbalyuk, O, Ivanov, A (2007) Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. Journal of Clinical Investigation 117: pp. 2105-2113 CrossRef
  34. Santos, FA, Frota, JT, Arruda, BR (2012) Antihyperglycemic and hypolipidemic effects of 伪, 尾-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice. Lipids in Health and Disease 11: pp. 98 CrossRef
  35. Haque, ME, Rahman, S, Rahmatullah, M, Jahan, R (2013) Evaluation of antihyperglycemic and antinociceptive activity of Xanthium indicum stem extract in Swiss albino mice. BMC Complementary and Alternative Medicine 13: pp. 296 CrossRef
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Rheumatology
  Internal Medicine
  Pharmacology and Toxicology
  Pathology
  
• 出版者：Springer Netherlands
• ISSN：1573-2576

文摘

Glibenclamide has a newly discovered role in inflammation regulation besides its antidiabetic effect. As an inhibitor of ATP-sensitive potassium (KATP) channel, glibenclamide antagonizes the relaxation of the tracheal smooth muscle. This indicates that glibenclamide might attenuate airway inflammation while aggravate airway hyperresponsiveness (AHR) in asthmatics. Clinically, many diabetics with asthma are prescribed with glibenclamide to control blood glucose. However, whether glibenclamide could exert any effects on asthmatic inflammation remains unknown. Using an ovalbumin (OVA)-induced mouse model of asthma, we evaluated the effects of glibenclamide on the AHR and inflammation. Interestingly, glibenclamide reduced all the cardinal features of asthma in OVA-challenged mice, including AHR, airway inflammation, and T-helper type 2 (Th2) cytokines. Glibenclamide also downregulated OVA-induced expressions of vascular cell adhesion molecule 1 (VCAM-1) and phosphorylated signal transducer and activator of transcription 6 (p-STAT6) in the lung. In addition, increased sulfonylurea receptor 1 (SUR1) expression in the lung was observed after the OVA challenge. These findings suggest that the classic sulfonylurea glibenclamide plays an important protective role in the development of asthma, which not only provides the evidence for the safety of prescribed glibenclamide in diabetics combined with asthma but also indicates a possible new therapeutic for asthma via targeting glibenclamide-related pathways.